QA: Dermata Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001853816_2026_Dermata_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001853816, Dermata Therapeutics Inc

  xvar xval
0 AssetsCurrent 0
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 7,863,826
4 LiabilitiesCurrent 460,811
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 1,179,635
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,900,117
9 ResearchAndDevelopmentExpense 3,609,495
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 215,055
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 7,863,826
1 Liabilities 1,640,446
2 Expenses 8,509,612
3 Revenues 0
4 StockholdersEquity 6,223,380
5 NetIncome -8,294,557
6 ComprehensiveNetIncome -8,294,557
7 BaseVar 9,114,470
8 EconomicCapitalRatiobeforeLimitedLiability 1.11
9 EconomicCapitalRatio 2.39

Edgar->Model Mapping

Feature Distribution

Change over Time